Report Overview
This report provides a deep insight into the global Chronic Liver Diseases Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Chronic Liver Diseases Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Chronic Liver Diseases Therapeutics market in any manner.
Global Chronic Liver Diseases Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Astellas Pharma
Bristol-Myers Squibb
Gilead Sciences
GlaxoSmithKline
F. Hoffmann-La Roche
Merck
Novartis
Sanofi
Pfizer
Takeda Pharmaceutical
Bausch Health
Theratechnologies
Alnylam Pharmaceuticals
Protagonist Therapeutics
Dicerna Pharmaceuticals
Endo International
Provectus Biopharmaceuticals
MAX BioPharma
Market Segmentation (by Type)
Chemotherapy Drugs
Targeted Therapy
Vaccines
Antiviral Drugs
Immunoglobulins
Corticosteroids
Others
Market Segmentation (by Application)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Geographic Segmentation
? North America (USA, Canada, Mexico)
? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
? South America (Brazil, Argentina, Columbia, Rest of South America)
? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
? Industry drivers, restraints, and opportunities covered in the study
? Neutral perspective on the market performance
? Recent industry trends and developments
? Competitive landscape & strategies of key players
? Potential & niche segments and regions exhibiting promising growth covered
? Historical, current, and projected market size, in terms of value
? In-depth analysis of the Chronic Liver Diseases Therapeutics Market
? Overview of the regional outlook of the Chronic Liver Diseases Therapeutics Market:
Key Reasons to Buy this Report:
? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
? This enables you to anticipate market changes to remain ahead of your competitors
? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
? Provision of market value (USD Billion) data for each segment and sub-segment
? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
? Provides insight into the market through Value Chain
? Market dynamics scenario, along with growth opportunities of the market in the years to come
? 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Chronic Liver Diseases Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Chronic Liver Diseases Therapeutics
1.2 Key Market Segments
1.2.1 Chronic Liver Diseases Therapeutics Segment by Type
1.2.2 Chronic Liver Diseases Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Chronic Liver Diseases Therapeutics Market Overview
2.1 Global Market Overview
2.1.1 Global Chronic Liver Diseases Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Chronic Liver Diseases Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Chronic Liver Diseases Therapeutics Market Competitive Landscape
3.1 Global Chronic Liver Diseases Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Chronic Liver Diseases Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Chronic Liver Diseases Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Chronic Liver Diseases Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Chronic Liver Diseases Therapeutics Sales Sites, Area Served, Product Type
3.6 Chronic Liver Diseases Therapeutics Market Competitive Situation and Trends
3.6.1 Chronic Liver Diseases Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Chronic Liver Diseases Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Chronic Liver Diseases Therapeutics Industry Chain Analysis
4.1 Chronic Liver Diseases Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Chronic Liver Diseases Therapeutics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Chronic Liver Diseases Therapeutics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Chronic Liver Diseases Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Chronic Liver Diseases Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Chronic Liver Diseases Therapeutics Price by Type (2019-2024)
7 Chronic Liver Diseases Therapeutics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Chronic Liver Diseases Therapeutics Market Sales by Application (2019-2024)
7.3 Global Chronic Liver Diseases Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Chronic Liver Diseases Therapeutics Sales Growth Rate by Application (2019-2024)
8 Chronic Liver Diseases Therapeutics Market Segmentation by Region
8.1 Global Chronic Liver Diseases Therapeutics Sales by Region
8.1.1 Global Chronic Liver Diseases Therapeutics Sales by Region
8.1.2 Global Chronic Liver Diseases Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Chronic Liver Diseases Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Chronic Liver Diseases Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Chronic Liver Diseases Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Chronic Liver Diseases Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Chronic Liver Diseases Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Astellas Pharma
9.1.1 Astellas Pharma Chronic Liver Diseases Therapeutics Basic Information
9.1.2 Astellas Pharma Chronic Liver Diseases Therapeutics Product Overview
9.1.3 Astellas Pharma Chronic Liver Diseases Therapeutics Product Market Performance
9.1.4 Astellas Pharma Business Overview
9.1.5 Astellas Pharma Chronic Liver Diseases Therapeutics SWOT Analysis
9.1.6 Astellas Pharma Recent Developments
9.2 Bristol-Myers Squibb
9.2.1 Bristol-Myers Squibb Chronic Liver Diseases Therapeutics Basic Information
9.2.2 Bristol-Myers Squibb Chronic Liver Diseases Therapeutics Product Overview
9.2.3 Bristol-Myers Squibb Chronic Liver Diseases Therapeutics Product Market Performance
9.2.4 Bristol-Myers Squibb Business Overview
9.2.5 Bristol-Myers Squibb Chronic Liver Diseases Therapeutics SWOT Analysis
9.2.6 Bristol-Myers Squibb Recent Developments
9.3 Gilead Sciences
9.3.1 Gilead Sciences Chronic Liver Diseases Therapeutics Basic Information
9.3.2 Gilead Sciences Chronic Liver Diseases Therapeutics Product Overview
9.3.3 Gilead Sciences Chronic Liver Diseases Therapeutics Product Market Performance
9.3.4 Gilead Sciences Chronic Liver Diseases Therapeutics SWOT Analysis
9.3.5 Gilead Sciences Business Overview
9.3.6 Gilead Sciences Recent Developments
9.4 GlaxoSmithKline
9.4.1 GlaxoSmithKline Chronic Liver Diseases Therapeutics Basic Information
9.4.2 GlaxoSmithKline Chronic Liver Diseases Therapeutics Product Overview
9.4.3 GlaxoSmithKline Chronic Liver Diseases Therapeutics Product Market Performance
9.4.4 GlaxoSmithKline Business Overview
9.4.5 GlaxoSmithKline Recent Developments
9.5 F. Hoffmann-La Roche
9.5.1 F. Hoffmann-La Roche Chronic Liver Diseases Therapeutics Basic Information
9.5.2 F. Hoffmann-La Roche Chronic Liver Diseases Therapeutics Product Overview
9.5.3 F. Hoffmann-La Roche Chronic Liver Diseases Therapeutics Product Market Performance
9.5.4 F. Hoffmann-La Roche Business Overview
9.5.5 F. Hoffmann-La Roche Recent Developments
9.6 Merck
9.6.1 Merck Chronic Liver Diseases Therapeutics Basic Information
9.6.2 Merck Chronic Liver Diseases Therapeutics Product Overview
9.6.3 Merck Chronic Liver Diseases Therapeutics Product Market Performance
9.6.4 Merck Business Overview
9.6.5 Merck Recent Developments
9.7 Novartis
9.7.1 Novartis Chronic Liver Diseases Therapeutics Basic Information
9.7.2 Novartis Chronic Liver Diseases Therapeutics Product Overview
9.7.3 Novartis Chronic Liver Diseases Therapeutics Product Market Performance
9.7.4 Novartis Business Overview
9.7.5 Novartis Recent Developments
9.8 Sanofi
9.8.1 Sanofi Chronic Liver Diseases Therapeutics Basic Information
9.8.2 Sanofi Chronic Liver Diseases Therapeutics Product Overview
9.8.3 Sanofi Chronic Liver Diseases Therapeutics Product Market Performance
9.8.4 Sanofi Business Overview
9.8.5 Sanofi Recent Developments
9.9 Pfizer
9.9.1 Pfizer Chronic Liver Diseases Therapeutics Basic Information
9.9.2 Pfizer Chronic Liver Diseases Therapeutics Product Overview
9.9.3 Pfizer Chronic Liver Diseases Therapeutics Product Market Performance
9.9.4 Pfizer Business Overview
9.9.5 Pfizer Recent Developments
9.10 Takeda Pharmaceutical
9.10.1 Takeda Pharmaceutical Chronic Liver Diseases Therapeutics Basic Information
9.10.2 Takeda Pharmaceutical Chronic Liver Diseases Therapeutics Product Overview
9.10.3 Takeda Pharmaceutical Chronic Liver Diseases Therapeutics Product Market Performance
9.10.4 Takeda Pharmaceutical Business Overview
9.10.5 Takeda Pharmaceutical Recent Developments
9.11 Bausch Health
9.11.1 Bausch Health Chronic Liver Diseases Therapeutics Basic Information
9.11.2 Bausch Health Chronic Liver Diseases Therapeutics Product Overview
9.11.3 Bausch Health Chronic Liver Diseases Therapeutics Product Market Performance
9.11.4 Bausch Health Business Overview
9.11.5 Bausch Health Recent Developments
9.12 Theratechnologies
9.12.1 Theratechnologies Chronic Liver Diseases Therapeutics Basic Information
9.12.2 Theratechnologies Chronic Liver Diseases Therapeutics Product Overview
9.12.3 Theratechnologies Chronic Liver Diseases Therapeutics Product Market Performance
9.12.4 Theratechnologies Business Overview
9.12.5 Theratechnologies Recent Developments
9.13 Alnylam Pharmaceuticals
9.13.1 Alnylam Pharmaceuticals Chronic Liver Diseases Therapeutics Basic Information
9.13.2 Alnylam Pharmaceuticals Chronic Liver Diseases Therapeutics Product Overview
9.13.3 Alnylam Pharmaceuticals Chronic Liver Diseases Therapeutics Product Market Performance
9.13.4 Alnylam Pharmaceuticals Business Overview
9.13.5 Alnylam Pharmaceuticals Recent Developments
9.14 Protagonist Therapeutics
9.14.1 Protagonist Therapeutics Chronic Liver Diseases Therapeutics Basic Information
9.14.2 Protagonist Therapeutics Chronic Liver Diseases Therapeutics Product Overview
9.14.3 Protagonist Therapeutics Chronic Liver Diseases Therapeutics Product Market Performance
9.14.4 Protagonist Therapeutics Business Overview
9.14.5 Protagonist Therapeutics Recent Developments
9.15 Dicerna Pharmaceuticals
9.15.1 Dicerna Pharmaceuticals Chronic Liver Diseases Therapeutics Basic Information
9.15.2 Dicerna Pharmaceuticals Chronic Liver Diseases Therapeutics Product Overview
9.15.3 Dicerna Pharmaceuticals Chronic Liver Diseases Therapeutics Product Market Performance
9.15.4 Dicerna Pharmaceuticals Business Overview
9.15.5 Dicerna Pharmaceuticals Recent Developments
9.16 Endo International
9.16.1 Endo International Chronic Liver Diseases Therapeutics Basic Information
9.16.2 Endo International Chronic Liver Diseases Therapeutics Product Overview
9.16.3 Endo International Chronic Liver Diseases Therapeutics Product Market Performance
9.16.4 Endo International Business Overview
9.16.5 Endo International Recent Developments
9.17 Provectus Biopharmaceuticals
9.17.1 Provectus Biopharmaceuticals Chronic Liver Diseases Therapeutics Basic Information
9.17.2 Provectus Biopharmaceuticals Chronic Liver Diseases Therapeutics Product Overview
9.17.3 Provectus Biopharmaceuticals Chronic Liver Diseases Therapeutics Product Market Performance
9.17.4 Provectus Biopharmaceuticals Business Overview
9.17.5 Provectus Biopharmaceuticals Recent Developments
9.18 MAX BioPharma
9.18.1 MAX BioPharma Chronic Liver Diseases Therapeutics Basic Information
9.18.2 MAX BioPharma Chronic Liver Diseases Therapeutics Product Overview
9.18.3 MAX BioPharma Chronic Liver Diseases Therapeutics Product Market Performance
9.18.4 MAX BioPharma Business Overview
9.18.5 MAX BioPharma Recent Developments
10 Chronic Liver Diseases Therapeutics Market Forecast by Region
10.1 Global Chronic Liver Diseases Therapeutics Market Size Forecast
10.2 Global Chronic Liver Diseases Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Chronic Liver Diseases Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Chronic Liver Diseases Therapeutics Market Size Forecast by Region
10.2.4 South America Chronic Liver Diseases Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Chronic Liver Diseases Therapeutics by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Chronic Liver Diseases Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Chronic Liver Diseases Therapeutics by Type (2025-2030)
11.1.2 Global Chronic Liver Diseases Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Chronic Liver Diseases Therapeutics by Type (2025-2030)
11.2 Global Chronic Liver Diseases Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Chronic Liver Diseases Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Chronic Liver Diseases Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Chronic Liver Diseases Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Chronic Liver Diseases Therapeutics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Chronic Liver Diseases Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Chronic Liver Diseases Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Chronic Liver Diseases Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Liver Diseases Therapeutics as of 2022)
Table 10. Global Market Chronic Liver Diseases Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Chronic Liver Diseases Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Chronic Liver Diseases Therapeutics Product Type
Table 13. Global Chronic Liver Diseases Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Chronic Liver Diseases Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Chronic Liver Diseases Therapeutics Market Challenges
Table 22. Global Chronic Liver Diseases Therapeutics Sales by Type (K Units)
Table 23. Global Chronic Liver Diseases Therapeutics Market Size by Type (M USD)
Table 24. Global Chronic Liver Diseases Therapeutics Sales (K Units) by Type (2019-2024)
Table 25. Global Chronic Liver Diseases Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Chronic Liver Diseases Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Chronic Liver Diseases Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Chronic Liver Diseases Therapeutics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Chronic Liver Diseases Therapeutics Sales (K Units) by Application
Table 30. Global Chronic Liver Diseases Therapeutics Market Size by Application
Table 31. Global Chronic Liver Diseases Therapeutics Sales by Application (2019-2024) & (K Units)
Table 32. Global Chronic Liver Diseases Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Chronic Liver Diseases Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Chronic Liver Diseases Therapeutics Market Share by Application (2019-2024)
Table 35. Global Chronic Liver Diseases Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Chronic Liver Diseases Therapeutics Sales by Region (2019-2024) & (K Units)
Table 37. Global Chronic Liver Diseases Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Chronic Liver Diseases Therapeutics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Chronic Liver Diseases Therapeutics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Chronic Liver Diseases Therapeutics Sales by Region (2019-2024) & (K Units)
Table 41. South America Chronic Liver Diseases Therapeutics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Chronic Liver Diseases Therapeutics Sales by Region (2019-2024) & (K Units)
Table 43. Astellas Pharma Chronic Liver Diseases Therapeutics Basic Information
Table 44. Astellas Pharma Chronic Liver Diseases Therapeutics Product Overview
Table 45. Astellas Pharma Chronic Liver Diseases Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Astellas Pharma Business Overview
Table 47. Astellas Pharma Chronic Liver Diseases Therapeutics SWOT Analysis
Table 48. Astellas Pharma Recent Developments
Table 49. Bristol-Myers Squibb Chronic Liver Diseases Therapeutics Basic Information
Table 50. Bristol-Myers Squibb Chronic Liver Diseases Therapeutics Product Overview
Table 51. Bristol-Myers Squibb Chronic Liver Diseases Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Bristol-Myers Squibb Business Overview
Table 53. Bristol-Myers Squibb Chronic Liver Diseases Therapeutics SWOT Analysis
Table 54. Bristol-Myers Squibb Recent Developments
Table 55. Gilead Sciences Chronic Liver Diseases Therapeutics Basic Information
Table 56. Gilead Sciences Chronic Liver Diseases Therapeutics Product Overview
Table 57. Gilead Sciences Chronic Liver Diseases Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Gilead Sciences Chronic Liver Diseases Therapeutics SWOT Analysis
Table 59. Gilead Sciences Business Overview
Table 60. Gilead Sciences Recent Developments
Table 61. GlaxoSmithKline Chronic Liver Diseases Therapeutics Basic Information
Table 62. GlaxoSmithKline Chronic Liver Diseases Therapeutics Product Overview
Table 63. GlaxoSmithKline Chronic Liver Diseases Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. GlaxoSmithKline Business Overview
Table 65. GlaxoSmithKline Recent Developments
Table 66. F. Hoffmann-La Roche Chronic Liver Diseases Therapeutics Basic Information
Table 67. F. Hoffmann-La Roche Chronic Liver Diseases Therapeutics Product Overview
Table 68. F. Hoffmann-La Roche Chronic Liver Diseases Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. F. Hoffmann-La Roche Business Overview
Table 70. F. Hoffmann-La Roche Recent Developments
Table 71. Merck Chronic Liver Diseases Therapeutics Basic Information
Table 72. Merck Chronic Liver Diseases Therapeutics Product Overview
Table 73. Merck Chronic Liver Diseases Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Merck Business Overview
Table 75. Merck Recent Developments
Table 76. Novartis Chronic Liver Diseases Therapeutics Basic Information
Table 77. Novartis Chronic Liver Diseases Therapeutics Product Overview
Table 78. Novartis Chronic Liver Diseases Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Novartis Business Overview
Table 80. Novartis Recent Developments
Table 81. Sanofi Chronic Liver Diseases Therapeutics Basic Information
Table 82. Sanofi Chronic Liver Diseases Therapeutics Product Overview
Table 83. Sanofi Chronic Liver Diseases Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Sanofi Business Overview
Table 85. Sanofi Recent Developments
Table 86. Pfizer Chronic Liver Diseases Therapeutics Basic Information
Table 87. Pfizer Chronic Liver Diseases Therapeutics Product Overview
Table 88. Pfizer Chronic Liver Diseases Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Pfizer Business Overview
Table 90. Pfizer Recent Developments
Table 91. Takeda Pharmaceutical Chronic Liver Diseases Therapeutics Basic Information
Table 92. Takeda Pharmaceutical Chronic Liver Diseases Therapeutics Product Overview
Table 93. Takeda Pharmaceutical Chronic Liver Diseases Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Takeda Pharmaceutical Business Overview
Table 95. Takeda Pharmaceutical Recent Developments
Table 96. Bausch Health Chronic Liver Diseases Therapeutics Basic Information
Table 97. Bausch Health Chronic Liver Diseases Therapeutics Product Overview
Table 98. Bausch Health Chronic Liver Diseases Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Bausch Health Business Overview
Table 100. Bausch Health Recent Developments
Table 101. Theratechnologies Chronic Liver Diseases Therapeutics Basic Information
Table 102. Theratechnologies Chronic Liver Diseases Therapeutics Product Overview
Table 103. Theratechnologies Chronic Liver Diseases Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Theratechnologies Business Overview
Table 105. Theratechnologies Recent Developments
Table 106. Alnylam Pharmaceuticals Chronic Liver Diseases Therapeutics Basic Information
Table 107. Alnylam Pharmaceuticals Chronic Liver Diseases Therapeutics Product Overview
Table 108. Alnylam Pharmaceuticals Chronic Liver Diseases Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Alnylam Pharmaceuticals Business Overview
Table 110. Alnylam Pharmaceuticals Recent Developments
Table 111. Protagonist Therapeutics Chronic Liver Diseases Therapeutics Basic Information
Table 112. Protagonist Therapeutics Chronic Liver Diseases Therapeutics Product Overview
Table 113. Protagonist Therapeutics Chronic Liver Diseases Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Protagonist Therapeutics Business Overview
Table 115. Protagonist Therapeutics Recent Developments
Table 116. Dicerna Pharmaceuticals Chronic Liver Diseases Therapeutics Basic Information
Table 117. Dicerna Pharmaceuticals Chronic Liver Diseases Therapeutics Product Overview
Table 118. Dicerna Pharmaceuticals Chronic Liver Diseases Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Dicerna Pharmaceuticals Business Overview
Table 120. Dicerna Pharmaceuticals Recent Developments
Table 121. Endo International Chronic Liver Diseases Therapeutics Basic Information
Table 122. Endo International Chronic Liver Diseases Therapeutics Product Overview
Table 123. Endo International Chronic Liver Diseases Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Endo International Business Overview
Table 125. Endo International Recent Developments
Table 126. Provectus Biopharmaceuticals Chronic Liver Diseases Therapeutics Basic Information
Table 127. Provectus Biopharmaceuticals Chronic Liver Diseases Therapeutics Product Overview
Table 128. Provectus Biopharmaceuticals Chronic Liver Diseases Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Provectus Biopharmaceuticals Business Overview
Table 130. Provectus Biopharmaceuticals Recent Developments
Table 131. MAX BioPharma Chronic Liver Diseases Therapeutics Basic Information
Table 132. MAX BioPharma Chronic Liver Diseases Therapeutics Product Overview
Table 133. MAX BioPharma Chronic Liver Diseases Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. MAX BioPharma Business Overview
Table 135. MAX BioPharma Recent Developments
Table 136. Global Chronic Liver Diseases Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 137. Global Chronic Liver Diseases Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 138. North America Chronic Liver Diseases Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 139. North America Chronic Liver Diseases Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 140. Europe Chronic Liver Diseases Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 141. Europe Chronic Liver Diseases Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 142. Asia Pacific Chronic Liver Diseases Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 143. Asia Pacific Chronic Liver Diseases Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 144. South America Chronic Liver Diseases Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 145. South America Chronic Liver Diseases Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 146. Middle East and Africa Chronic Liver Diseases Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 147. Middle East and Africa Chronic Liver Diseases Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 148. Global Chronic Liver Diseases Therapeutics Sales Forecast by Type (2025-2030) & (K Units)
Table 149. Global Chronic Liver Diseases Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 150. Global Chronic Liver Diseases Therapeutics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 151. Global Chronic Liver Diseases Therapeutics Sales (K Units) Forecast by Application (2025-2030)
Table 152. Global Chronic Liver Diseases Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Chronic Liver Diseases Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Chronic Liver Diseases Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Chronic Liver Diseases Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Chronic Liver Diseases Therapeutics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Chronic Liver Diseases Therapeutics Market Size by Country (M USD)
Figure 11. Chronic Liver Diseases Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Chronic Liver Diseases Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Chronic Liver Diseases Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Chronic Liver Diseases Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Chronic Liver Diseases Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Chronic Liver Diseases Therapeutics Market Share by Type
Figure 18. Sales Market Share of Chronic Liver Diseases Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Chronic Liver Diseases Therapeutics by Type in 2023
Figure 20. Market Size Share of Chronic Liver Diseases Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Chronic Liver Diseases Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Chronic Liver Diseases Therapeutics Market Share by Application
Figure 24. Global Chronic Liver Diseases Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Chronic Liver Diseases Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Chronic Liver Diseases Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Chronic Liver Diseases Therapeutics Market Share by Application in 2023
Figure 28. Global Chronic Liver Diseases Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Chronic Liver Diseases Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Chronic Liver Diseases Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Chronic Liver Diseases Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Chronic Liver Diseases Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Chronic Liver Diseases Therapeutics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Chronic Liver Diseases Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Chronic Liver Diseases Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Chronic Liver Diseases Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Chronic Liver Diseases Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Chronic Liver Diseases Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Chronic Liver Diseases Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Chronic Liver Diseases Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Chronic Liver Diseases Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Chronic Liver Diseases Therapeutics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Chronic Liver Diseases Therapeutics Sales Market Share by Region in 2023
Figure 44. China Chronic Liver Diseases Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Chronic Liver Diseases Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Chronic Liver Diseases Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Chronic Liver Diseases Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Chronic Liver Diseases Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Chronic Liver Diseases Therapeutics Sales and Growth Rate (K Units)
Figure 50. South America Chronic Liver Diseases Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Chronic Liver Diseases Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Chronic Liver Diseases Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Chronic Liver Diseases Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Chronic Liver Diseases Therapeutics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Chronic Liver Diseases Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Chronic Liver Diseases Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Chronic Liver Diseases Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Chronic Liver Diseases Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Chronic Liver Diseases Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Chronic Liver Diseases Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Chronic Liver Diseases Therapeutics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Chronic Liver Diseases Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Chronic Liver Diseases Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Chronic Liver Diseases Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Chronic Liver Diseases Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Chronic Liver Diseases Therapeutics Market Share Forecast by Application (2025-2030)
